Literature DB >> 35165436

Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology.

Claudia D Fuchs1, Michael Trauner2.   

Abstract

Bile acids (BAs) can regulate their own metabolism and transport as well as other key aspects of metabolic homeostasis via dedicated (nuclear and G protein-coupled) receptors. Disrupted BA transport and homeostasis results in the development of cholestatic disorders and contributes to a wide range of liver diseases, including nonalcoholic fatty liver disease and hepatocellular and cholangiocellular carcinoma. Furthermore, impaired BA homeostasis can also affect the intestine, contributing to the pathogenesis of irritable bowel syndrome, inflammatory bowel disease, and colorectal and oesophageal cancer. Here, we provide a summary of the role of BAs and their disrupted homeostasis in the development of gastrointestinal and hepatic disorders and present novel insights on how targeting BA pathways might contribute to novel treatment strategies for these disorders.
© 2022. Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35165436     DOI: 10.1038/s41575-021-00566-7

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   73.082


  284 in total

1.  TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation.

Authors:  Alessia Perino; Thijs Willem Hendrik Pols; Mitsunori Nomura; Sokrates Stein; Roberto Pellicciari; Kristina Schoonjans
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

2.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.

Authors:  H Wang; J Chen; K Hollister; L C Sowers; B M Forman
Journal:  Mol Cell       Date:  1999-05       Impact factor: 17.970

3.  Identification of a nuclear receptor for bile acids.

Authors:  M Makishima; A Y Okamoto; J J Repa; H Tu; R M Learned; A Luk; M V Hull; K D Lustig; D J Mangelsdorf; B Shan
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

4.  Bile acids: natural ligands for an orphan nuclear receptor.

Authors:  D J Parks; S G Blanchard; R K Bledsoe; G Chandra; T G Consler; S A Kliewer; J B Stimmel; T M Willson; A M Zavacki; D D Moore; J M Lehmann
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

5.  Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.

Authors:  Mitsuhiro Watanabe; Sander M Houten; Chikage Mataki; Marcelo A Christoffolete; Brian W Kim; Hiroyuki Sato; Nadia Messaddeq; John W Harney; Osamu Ezaki; Tatsuhiko Kodama; Kristina Schoonjans; Antonio C Bianco; Johan Auwerx
Journal:  Nature       Date:  2006-01-08       Impact factor: 49.962

Review 6.  Biliary secretion and excretion in health and disease: current concepts.

Authors:  Alan F Hofmann
Journal:  Ann Hepatol       Date:  2007 Jan-Mar       Impact factor: 2.400

Review 7.  Nuclear receptors in bile acid metabolism.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

Review 8.  Farnesoid X Receptor Agonists and Other Bile Acid Signaling Strategies for Treatment of Liver Disease.

Authors:  Emina Halilbasic; Claudia Fuchs; Stefan Traussnigg; Michael Trauner
Journal:  Dig Dis       Date:  2016-06-22       Impact factor: 2.404

9.  TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease.

Authors:  Kazuaki Yoneno; Tadakazu Hisamatsu; Katsuyoshi Shimamura; Nobuhiko Kamada; Riko Ichikawa; Mina T Kitazume; Maiko Mori; Michihide Uo; Yuka Namikawa; Katsuyoshi Matsuoka; Toshiro Sato; Kazutaka Koganei; Akira Sugita; Takanori Kanai; Toshifumi Hibi
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

Review 10.  Bile acid receptors as targets for drug development.

Authors:  Frank G Schaap; Michael Trauner; Peter L M Jansen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-08-27       Impact factor: 46.802

View more
  7 in total

Review 1.  New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease.

Authors:  Yali Liu; Tao Liu; Xu Zhao; Yanhang Gao
Journal:  Cell Mol Life Sci       Date:  2022-08-17       Impact factor: 9.207

Review 2.  Bile acids and the gut microbiota: metabolic interactions and impacts on disease.

Authors:  Stephanie L Collins; Jonathan G Stine; Jordan E Bisanz; C Denise Okafor; Andrew D Patterson
Journal:  Nat Rev Microbiol       Date:  2022-10-17       Impact factor: 78.297

3.  Alteration of Bile Acids and Omega-6 PUFAs Are Correlated With the Progression and Prognosis of Drug-Induced Liver Injury.

Authors:  Shuang Zhao; Haoshuang Fu; Tianhui Zhou; Minghao Cai; Yan Huang; Qinyi Gan; Chenxi Zhang; Cong Qian; Jiexiao Wang; Zhenglan Zhang; Xiaolin Wang; Xiaogang Xiang; Qing Xie
Journal:  Front Immunol       Date:  2022-04-12       Impact factor: 8.786

Review 4.  Hepatocellular carcinoma: Novel understandings and therapeutic strategies based on bile acids (Review).

Authors:  Wenyu Luo; Shiqi Guo; Yang Zhou; Junfeng Zhu; Jingwen Zhao; Mengyao Wang; Lixuan Sang; Bingyuan Wang; Bing Chang
Journal:  Int J Oncol       Date:  2022-08-05       Impact factor: 5.884

Review 5.  The Effect of Lithocholic Acid on the Gut-Liver Axis.

Authors:  Wei Sheng; Guang Ji; Li Zhang
Journal:  Front Pharmacol       Date:  2022-07-07       Impact factor: 5.988

Review 6.  Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives.

Authors:  Maria Pallozzi; Natalia Di Tommaso; Valeria Maccauro; Francesco Santopaolo; Antonio Gasbarrini; Francesca Romana Ponziani; Maurizio Pompili
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

Review 7.  Intestinal homeostasis in autoimmune liver diseases.

Authors:  Qiaoyan Liu; Wei He; Ruqi Tang; Xiong Ma
Journal:  Chin Med J (Engl)       Date:  2022-07-20       Impact factor: 6.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.